Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinoma

Cancer Biology & Therapy
Vandana Singh KushwahaAshim Ghatak

Abstract

This study compared the efficacy and toxicity of Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil (5-FU) in patients of recurrent squamous cell carcinoma of head and neck (SCCHN) treated with palliative intent. Patients with recurrent SCCHN not amenable to curative treatment were randomly assigned to Gefitinib, Methotrexate or Methotrexate plus 5-FU arm. The primary end point was overall survival. Secondary end points of interest were objective response rate, toxicity and quality of life. Total 117 patients were analyzed. Median overall survival and objective response rates were 8.8 months, 7.8 months and 8.1 months and 7.7%, 5.0% and 7.9% in Gefitinib, Methotrexate and Methotrexate plus 5-FU arms respectively with no statistically significant difference between 3 arms. Gefitinib had different toxicity profile compared with other arms. Majority of toxicities were Grade 1 or Grade 2. Gefitinib had significant improvement in quality of life during initial months over Methotrexate. There was no suggestion that Gefitinib significantly prolonged overall survival compared with Methotrexate and Methotrexate plus 5-FU. However, improved Quality of Life with manageable toxicities was observed.

References

Aug 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A A ForastiereS K Williamson
Feb 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C JacobsL Schacter
Dec 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G P BrowmanM N Levine
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F CellaJ Brannon
Nov 1, 2002·Cancer Control : Journal of the Moffitt Cancer Center·Muhyi Al-Sarraf
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ezra E W CohenEverett E Vokes
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·K Kian AngLuka Milas
Jul 12, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Masayuki ShirakiHiroyoshi Hiratsuka
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara BurtnessUNKNOWN Eastern Cooperative Oncology Group
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ezra E W CohenEverett E Vokes
Jun 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Dimitrios Colevas
Jun 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shailaja Kalyankrishna, Jennifer R Grandis
Sep 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine H ChungFred R Hirsch
Mar 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Simon W StewartEverett E Vokes
Oct 16, 2009·Expert Review of Anticancer Therapy·Fernando RiveraLourdes Gutiérrez-Sanz
Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J B Vermorken, P Specenier
Jan 19, 2012·Current Treatment Options in Oncology·Katharine A R Price, Ezra E Cohen

❮ Previous
Next ❯

Citations

Aug 25, 2015·Clinical Oral Investigations·Stefan HartmannUrs D A Müller-Richter
Mar 21, 2019·Current Opinion in Oncology·Esma Saada-BouzidJoël Guigay
Jan 5, 2020·Expert Review of Anticancer Therapy·Akhil RajendraKumar Prabhash
May 20, 2020·International Journal of Molecular Sciences·Przemysław KoźmińskiEwa Gniazdowska
Jun 27, 2019·Current Treatment Options in Oncology·Joël GuigayCécile Michel
Sep 22, 2018·Oncotarget·Hunter John PiegolsVilma Yuzbasiyan-Gurkan

❮ Previous
Next ❯

Software Mentioned

GEFITINIB

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

© 2022 Meta ULC. All rights reserved